MedTrace Logo

Observation of Clinical Consistency of Organoid-chips Drug Sensitivity in Chemotherapy for PCa With Visceral Metastasis

NCT06536725 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2024-08-05

No results posted yet for this study

Summary

This project plans to establish an organoid chip model of prostate cancer patients with internal organ metastasis from surgical or biopsy tissue sources, and test the sensitivity of commonly used chemotherapy drugs based on organoid chip drug sensitivity testing technology to screen out sensitive individualized treatment plans.

Conditions

Interventions

OTHER

Building Organoid-on-chips models

This project obtains surgical or biopsy samples from prostate cancer patients with visceral metastasis for the construction of organoids.

Sponsors & Collaborators

  • Tianjin Medical University Second Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-11-01
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06536725 on ClinicalTrials.gov